Puma Biotechnology Inc · NASDAQ:PBYI
Puma Biotechnology — Q3 2026 Earnings Presentation
8 slides from Puma Biotechnology's earnings presentation, Nov 5, 2026
Slide 1: Puma Biotechnology Earnings Call Commercial Update
Puma Biotechnology Earnings Call Commercial Update November 5, 2026
Slide 2: Forward-Looking Safe-Harbor Statement
Forward-Looking Safe-Harbor Statement This presentation contains forward-looking statements, including statements regarding commercialization of NERLYNX® and the potential indications and development of our drug candidates. All forward-looking statements involve risks and uncertainties that could ca
Slide 3: Puma's Pharmacy and Distributor Network
Puma’s Pharmacy and Distributor Network Hub Services Specialty Pharmacy Network (SP) Accredo CVS ONCO360 Patients Optum / Biologics Diplomat Specialty Distributor Network (SD) Sites of Care McKesson Academic Hospitals ASD / Oncology Supply Community Hospitals Cardinal Health Physician Practices DMS
Slide 4: $54.1 Million Net NERLYNX Revenue in Q3'26
$54.1 Million Net NERLYNX Revenue in Q3’26 ~5% increase in Q3’26 compared to Q3’25 ~1% increase in Q3’26 compared to Q2’26 Net Revenue (in $MM) Net Revenue (in $MM) 54.1 53.6 54.1 51.9 Q3'25 Q3'26 Q2'26 Q3'26 Inventory Change ($) Inventory Change ($) Q3’25 Q3’26 Q2’26 Q3’26 $3.1 mil -$1.5 mil -$1 mi
Slide 5: 2,818 Ex-Factory Bottles Were Sold in Q3'26
2,818 Ex-Factory Bottles Were Sold in Q3’26 ~4% decrease in Q3’26 compared to Q3’25 ~4% decrease in Q3’26 compared to Q2’26 Bottles Bottles 2,949 2,929 2,818 2,818 Q3'25 Q3'26 Q2'26 Q3'26 Copyright 2026 Puma Biotechnology 5
Slide 6: 2,899 bottles of U.S. Commercial Demand in Q3'26
2,899 bottles of U.S. Commercial Demand in Q3’26 ~5% increase in Q3’26 compared to Q3’25 ~3% decrease in Q3’26 compared to Q2’26 Bottles Bottles 2,899 2,986 2,899 2,768 Q3'25 Q3'26 Q2'26 Q3'26 Copyright 2026 Puma Biotechnology 6
Slide 7: Rest of World Partnerships – Timelines
Rest of World Partnerships – Timelines Region Partner Regulatory Approvals Commercial Launches • 2019 – Ext. Adj. in Australia, Singapore • 2020 – Ext. Adj. in Brunei, Malaysia, New Zealand • 2020 – Singapore Australia / SE Asia • 2022 – Ext. Adj. in the Philippines; mBC in Singapore • 2021 – Malays
Slide 8: Puma Biotechnology Earnings Call Commercial Update
Puma Biotechnology Earnings Call Commercial Update November 5, 2026